| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Heng Shao, Heyue Du, Quan Gan, Dequan Ye, Zhuangfei Chen, Yanqing Zhu, Shasha Zhu, Lang Qu, Junyan Lu, Yutong Li, Jing Duan, Yingqi Gu, Meiling Che. Trends of the Global Burden of Disease Attributable to Cannabis Use Disorder in 204 Countries and Territories, 1990-2019: Results from the Disease Burden Study 2019. International journal of mental health and addiction. 2023-02-23. PMID:36817983. |
we analyzed data from the 2019 global burden of disease study (gbd) to estimate the incidence and prevalence of cannabis use disorder (cud) and calculated the disease burden of cud in 204 countries and territories and 21 regions over the past three decades. |
2023-02-23 |
2023-08-14 |
Not clear |
| Heng Shao, Heyue Du, Quan Gan, Dequan Ye, Zhuangfei Chen, Yanqing Zhu, Shasha Zhu, Lang Qu, Junyan Lu, Yutong Li, Jing Duan, Yingqi Gu, Meiling Che. Trends of the Global Burden of Disease Attributable to Cannabis Use Disorder in 204 Countries and Territories, 1990-2019: Results from the Disease Burden Study 2019. International journal of mental health and addiction. 2023-02-23. PMID:36817983. |
nearly 200 million individuals are cannabis users worldwide, and cud is a notable condition of gbd. |
2023-02-23 |
2023-08-14 |
Not clear |
| Johannes Thrul, Jill A Rabinowitz, Beth A Reboussin, Brion S Maher, James C Anthony, Nicholas S Ialong. Longitudinal associations between age 20 problematic substance use and opioid use disorder incidence at age 30 - findings from an urban cohort. Journal of psychiatric research. vol 160. 2023-02-10. PMID:36764195. |
lifetime cannabis use disorder (cud), alcohol use disorder (aud; both dsm-iv), and current nicotine dependence (fagerstrom test for nicotine dependence, ftnd) assessed at age 20 were used to predict (1) dsm-iv lifetime oud at age 30, and (2) oud criteria between ages 20 and 30 in multivariable logistic regression models. |
2023-02-10 |
2023-08-14 |
human |
| Rynaz Rabiee, Hugo Sjöqvist, Emilie Agardh, Andreas Lundin, Anna-Karin Danielsso. Risk of readmission among individuals with cannabis use disorder during a 15-year cohort study: The impact of socioeconomic factors and psychiatric comorbidity. Addiction (Abingdon, England). 2023-02-06. PMID:36746781. |
cannabis use disorder (cud) is one of the main reasons for seeking substance treatment in the nordic countries, yet there are few studies on readmission to care. |
2023-02-06 |
2023-08-14 |
Not clear |
| Joshua A Lile, Brian W Turner, David H Cox, Marcel O Bonn-Miller, Ned R Katz, Thomas P Shellenberg, William W Stoops, Justin C Stricklan. Cannabis Use Disorder Treatment Preferences: A Pilot Survey in Current Users of Cannabis. Journal of addiction medicine. 2023-02-02. PMID:36731101. |
highly effective treatments for cannabis use disorder (cud) are lacking, and patient preferences have not been considered during treatment development. |
2023-02-02 |
2023-08-14 |
Not clear |
| Erin A McClure, Leah Hamilton, Gillian L Schauer, Theresa E Matson, Gwen T Lapha. Cannabis and nicotine co-use among primary care patients in a state with legal cannabis access. Addictive behaviors. vol 140. 2023-01-27. PMID:36706676. |
outcomes included; prevalence of cannabis use, days of cannabis use per week and times used per day, methods of use, thc:cbd content, non-medical and/or medical use, health symptoms managed, and cannabis use disorder (cud) symptom severity. |
2023-01-27 |
2023-08-14 |
Not clear |
| Erin A McClure, Leah Hamilton, Gillian L Schauer, Theresa E Matson, Gwen T Lapha. Cannabis and nicotine co-use among primary care patients in a state with legal cannabis access. Addictive behaviors. vol 140. 2023-01-27. PMID:36706676. |
nicotine co-use (n = 352; 25.4 %) was associated with differences in method of cannabis use, thc:cbd content, days of use per week and times used per day, number of health symptoms managed, and cud severity (all p < 0.001), compared to primary care patients with cannabis-only use (n = 1036). |
2023-01-27 |
2023-08-14 |
Not clear |
| Justyne D Rodas, Maryam Sorkhou, Tony P Georg. Contingency Management for Treatment of Cannabis Use Disorder in Co-Occurring Mental Health Disorders: A Systematic Review. Brain sciences. vol 13. issue 1. 2023-01-21. PMID:36672017. |
amongst individuals with a mental health disorder, a comorbid diagnosis of cannabis use disorder (cud) is associated with numerous adverse consequences, including more severe symptom profiles, poorer treatment response, and reduced psychosocial functioning. |
2023-01-21 |
2023-08-14 |
Not clear |
| Justyne D Rodas, Maryam Sorkhou, Tony P Georg. Contingency Management for Treatment of Cannabis Use Disorder in Co-Occurring Mental Health Disorders: A Systematic Review. Brain sciences. vol 13. issue 1. 2023-01-21. PMID:36672017. |
contingency management (cm), a method to specifically reinforce target behavior attainment (e.g., substance use abstinence), may provide an effective intervention in treating cannabis use in patients with a dual diagnosis of cud and a mental health disorder. |
2023-01-21 |
2023-08-14 |
Not clear |
| Sarah Gutkind, Dvora Shmulewitz, Deborah Hasi. Sex differences in Cannabis use disorder and associated psychosocial problems among US adults, 2012-2013. Preventive medicine. 2023-01-14. PMID:36641126. |
while men show greater prevalence of cannabis use disorder (cud) than women, whether cannabis use frequency drives this difference is unknown, and little is known about sex differences in problems associated with cud. |
2023-01-14 |
2023-08-14 |
Not clear |
| Sarah Gutkind, Dvora Shmulewitz, Deborah Hasi. Sex differences in Cannabis use disorder and associated psychosocial problems among US adults, 2012-2013. Preventive medicine. 2023-01-14. PMID:36641126. |
cannabis use frequency, dsm-5 cud and problems (interpersonal, financial, legal, health-related) were assessed. |
2023-01-14 |
2023-08-14 |
Not clear |
| Sarah Gutkind, Dvora Shmulewitz, Deborah Hasi. Sex differences in Cannabis use disorder and associated psychosocial problems among US adults, 2012-2013. Preventive medicine. 2023-01-14. PMID:36641126. |
associations between psychosocial problems, sex and dsm-5 cud were assessed using prevalence differences (pd) and 95% confidence intervals (ci) from logistic regression models, controlling for demographics and cannabis use frequency, and effect modification by sex was assessed. |
2023-01-14 |
2023-08-14 |
Not clear |
| Sarah Gutkind, Dvora Shmulewitz, Deborah Hasi. Sex differences in Cannabis use disorder and associated psychosocial problems among US adults, 2012-2013. Preventive medicine. 2023-01-14. PMID:36641126. |
cud showed stronger associations for interpersonal problems among women than men, suggesting the need for particular emphasis on treating interpersonal problems related to cannabis use among women. |
2023-01-14 |
2023-08-14 |
Not clear |
| M Reza Jabalameli, Zhengdong D Zhan. Substance abuse and the risk of severe COVID-19: Mendelian randomization confirms the causal role of opioids but hints a negative causal effect for cannabinoids. Frontiers in genetics. vol 13. 2022-12-30. PMID:36583016. |
a recent study investigated the relationship between substance use disorders (sud) and the risk of severe covid-19 in the united states and concluded that the risk of hospitalization and death due to covid-19 is directly correlated with substance abuse, including opioid use disorder (oud) and cannabis use disorder (cud). |
2022-12-30 |
2023-08-14 |
Not clear |
| Emese Kroon, Alessandra Mansueto, Lauren Kuhns, Francesca Filbey, Reinout Wiers, Janna Cousij. Gender differences in cannabis use disorder symptoms: A network analysis. Drug and alcohol dependence. vol 243. 2022-12-24. PMID:36565568. |
while cannabis use in women is increasing worldwide, research into gender differences in cannabis use disorder (cud) symptomology is lacking. |
2022-12-24 |
2023-08-14 |
Not clear |
| Dongze Chen, Xinpei Wang, Tao Huang, Jinzhu Ji. Genetic support of a causal relationship between cannabis use and educational attainment: a two-sample Mendelian randomization study of European ancestry. Addiction (Abingdon, England). 2022-12-05. PMID:36465060. |
we tested the potential causal relationship between cannabis use disorder (cud) or lifetime cannabis use (lcu) and educational attainment. |
2022-12-05 |
2023-08-14 |
Not clear |
| Ovidiu Tatar, Amal Abdel-Baki, Anne Wittevrongel, Tania Lecomte, Jan Copeland, Pamela Lachance-Touchette, Stephanie Coronado-Montoya, José Côté, David Crockford, Simon Dubreucq, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Philip G Tibbo, Marie Villeneuve, Didier Jutras-Aswa. Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC). JMIR research protocols. vol 11. issue 11. 2022-11-25. PMID:36427227. |
cannabis use is the most prevalent among adolescents and young adults; frequent consumption is associated with cannabis use disorder (cud) and psychosis, with a high prevalence (up to 50%) of cud in individuals with first-episode psychosis (fep). |
2022-11-25 |
2023-08-14 |
Not clear |
| Ovidiu Tatar, Amal Abdel-Baki, Anne Wittevrongel, Tania Lecomte, Jan Copeland, Pamela Lachance-Touchette, Stephanie Coronado-Montoya, José Côté, David Crockford, Simon Dubreucq, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Philip G Tibbo, Marie Villeneuve, Didier Jutras-Aswa. Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC). JMIR research protocols. vol 11. issue 11. 2022-11-25. PMID:36427227. |
early intervention services (eis) for psychosis include face-to-face psychosocial interventions for cud, because reducing or discontinuing cannabis use improves clinical and health care service use outcomes. |
2022-11-25 |
2023-08-14 |
Not clear |
| Jean Chassagne, Patrick Raynal, Jonathan Bronchain, Henri Chabro. Smoking Mostly Alone as a Risk Factor for Cannabis Use Disorders and Depressive Symptoms. International journal of mental health and addiction. 2022-11-23. PMID:36415673. |
we evaluated how smoking mostly alone modulates cannabis use disorders (cud) and depressive symptoms in college students. |
2022-11-23 |
2023-08-14 |
Not clear |
| Jean Chassagne, Patrick Raynal, Jonathan Bronchain, Henri Chabro. Smoking Mostly Alone as a Risk Factor for Cannabis Use Disorders and Depressive Symptoms. International journal of mental health and addiction. 2022-11-23. PMID:36415673. |
a sample of 854 individuals from france (568 women, 286 men) who used cannabis in the last 6 months completed self-report questionnaires evaluating cannabis consumption, cud symptoms, and depressive symptoms. |
2022-11-23 |
2023-08-14 |
Not clear |